PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
02-Apr-2020 FDA ACCEPTS MESOBLAST’S BIOLOGICS LICENCE APPLICATION FOR RYONCIL™ AND AGREES TO PRIORITY REVIEW Mesoblast Limited
02-Apr-2020 Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™ Emergent BioSolutions
02-Apr-2020 Generation Bio and Vir Biotechnology to Collaborate on Research to Leverage Scalable Non-Viral Gene Therapy Platform for Durable Production of Monoclonal Antibodies Against Coronavirus That Causes COVID-19 Generation Bio
02-Apr-2020 INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia INOVIO Pharmaceuticals, Inc
02-Apr-2020 REGENERON ANNOUNCES AMERICAN COLLEGE OF CARDIOLOGY PRESENTATION OF POSITIVE PHASE 3 EVINACUMAB RESULTS IN PATIENTS WITH SEVERE INHERITED FORM OF HIGH CHOLESTEROL Regeneron Pharmaceuticals, Inc.
02-Apr-2020 Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines Eli Lilly and Company
02-Apr-2020 UTILITY Therapeutics Announces Leadership Changes UTILITY Therapeutics
02-Apr-2020 BCMPA WELCOMES NEW RULES GOVERNING THE MANUFACTURE OF HAND SANITISERS IN THE UK The British Contract Manufacturers and Packers Association (BCMPA)
02-Apr-2020 MANN+HUMMEL implements global activities and transfers its filter media competence to new markets MANN+HUMMEL
02-Apr-2020 Independent SMO Panthera Biopartners continues to expand its network of clinical trial sites Panthera Biopartners
02-Apr-2020 Due to COVID-19, Pain Therapeutics Conference will be accessed remotely SMi Group
02-Apr-2020 PCR Biosystems continues to scale up operations to ensure ongoing availability of COVID-19 test reagents PCR Biosystems
01-Apr-2020 Nordic Nanovector Announces Focus on Advancing PARADIGME and Actions to Extend Cash Runway into 2021 Nordic Nanovector
01-Apr-2020 PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical PHARMASEAL
01-Apr-2020 Neuraxpharm enters the medical cannabis market as the first-ever European pharmaceutical company to market medical cannabis products Neuraxpharm
01-Apr-2020 Sanofi: Information on Sanofi’s Shareholder General Meeting of Tuesday, April 28, 2020 Sanofi
01-Apr-2020 Scailyte Announces Its New Advisory Board, Composed of World Leading Clinicians and Scientists Scailyte
01-Apr-2020 Patient-administered pain-killer saves time and resources in emergency departments Almac Group
01-Apr-2020 Orgenesis and ExcellaBio announce breakthrough manufacturing process for Bioxomes, proprietary synthetic exosomes/extracellular vesicles (EV) Orgenesis
01-Apr-2020 Agilent Introduces New Handheld Raw Material ID System for Pharmaceutical Manufacturers Agilent Technologies